{{knowledge objective
|Identifiant=OIC-063-18-B
|Item_parent=Adolescent and adult schizophrenic disorders
|Item_parent_short=Adolescent and adult schizophrenic disorders
|Rank=B
|Title=Knowing the indications for long-term non-pharmacological treatment
|Description=None
|Heading=Management
|Contributors=Marie Tournier,Wissam El-Hage
|Order=18}}

Long-term pharmacological treatment must be combined with psychosocial care.

===Psychiatric follow-up===
Monitoring and preventing recidivism, monitoring medication compliance and safety.

Supportive psychotherapy focusing on adaptive resources, empathy and encouragement.

===Cognitive-behavioural psychotherapy===
Reducing the impact of persistent symptoms despite well-managed antipsychotic treatment.

===Therapeutic education===
Reduces the risk of relapse by educating patients and their families about the disease, its treatment and the organisation of care. The aim is to optimise the resources of patients and their families, as well as their capacity for self-care and adaptation. Therapeutic patient education helps to improve the patient's health, quality of life and that of his or her [[Overall support for a carer SD-330|next of kin]].

===Cognitive re-education===
Cognitive re-education techniques to improve cognitive functioning and/or social cognition.

===Psychosocial rehabilitation===
Rehabilitation and medico-social care to support patients in their daily or professional lives.